Compounds > 1,2,5,8-tetrahydroxy anthraquinone
Page last updated: 2024-11-03

1,2,5,8-tetrahydroxy anthraquinone and Prostatic Neoplasms

1,2,5,8-tetrahydroxy anthraquinone has been researched along with Prostatic Neoplasms in 1 studies

1,2,5,8-tetrahydroxy anthraquinone: structure in first source
quinalizarin : A tetrahydroxyanthraquinone having the four hydroxy groups at the 1-, 2-, 5- and 8-positions.

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schneider, CC1
Götz, C1
Hessenauer, A1
Günther, J1
Kartarius, S1
Montenarh, M1

Other Studies

1 other study available for 1,2,5,8-tetrahydroxy anthraquinone and Prostatic Neoplasms

ArticleYear
Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines.
    Molecular and cellular biochemistry, 2011, Volume: 356, Issue:1-2

    Topics: Anthraquinones; Apoptosis; Benzimidazoles; Casein Kinase II; CDC2 Protein Kinase; cdc25 Phosphatases

2011